The biological vaccine sector weakened, and Watson biology fell more than 6%
The biological vaccine sector weakened. As of press time, Watson biology fell by more than 6%, Zhifei biology and Boya biology fell by more than 5%, Changchun hi tech fell by more than 4%, and Wantai biology, kangxinuo and dongfulong followed suit.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
In-depth
Healthcare
Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 26, 2022 12:26 PM
Briefing May 19, 2022 05:45 PM
· Healthcare
Shenzhen textile A: the order of line 7 is full, and the production line speed is climbing
Healthcare
CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist
The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.
Sep 06, 2022 11:48 AM
Briefing Mar 15, 2022 12:19 PM
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Staples, Communication
An Entrepreneur and Her New Journey to Globalization
Sep 21, 2023 05:40 PM
Insight
In-depth
Industrials · Analysis
EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part I）
Sep 21, 2023 04:43 PM
Insight
In-depth